Table 1C. | Characteristics of the included articles |
Study |
Year of publication |
Type of study |
Groups | Treatment provided |
N patients |
N implants |
Follow-up (months) |
Diagnosis | Treatment outcomes |
Microbiological results |
Conclusions | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Self- performed |
Professionally- delivered |
Mucositis/ peri-implantitis |
PDs reduction Mean (SD), mm |
Radiographic MBL changes Mean (SD), mm |
BOP changes Mean (SD), mm |
Exudate changes |
PI or MPI (SD) changes |
CAL Mean (SD), mm |
Recession Mean (SD), mm |
|||||||||
Gomes et al. [29] | 2015 | Single-arm cohort | Test |
Multi-tufted TB, dental floss and/or interdental TB.
Non-therapeutic fluoride toothpaste |
Weekly supragingival/ supramucosal MD for 1 month, then every 3 months |
14 | 59 | 13 | Mucositis |
3.62 (0.31) to 2.55 (0.16) |
NA |
Sites: 54.05 (5.88) to 4.96 (1.78)% |
NA |
18.98 (5.89) to 2.7 (1.47)% /390 days |
NA | NA | NA | The supragingival-supramucosal biofilm control benefited both teeth and implants |
Corbella et al. [30] | 2011 | Non-controlled prospective study | Mucositis | CHX 0.2% mouthwash twice a day for 10 days, interdental brushes | Powered and manual devices MD | 61 | 244 | 60 | Mucositis |
2.2 (0.87) to 2.46 (0.5) |
NA |
Sites: Index 0: 88.2 to 100% Index 1: 1.4 to 0%; Index 2: 10.4 to 0%; Index 3: 0 to 0%. |
NA |
Sites/6 and 58 months Index 0: 58.3% to 88.5%; Index 1: 2.8 to 7.3%; Index 2: 9.7 to 1%; Index 3: 29.2 to 3.2% |
NA | NA | NA | Systematic hygienic protocol is effective in keeping low the incidence of peri-implant mucositis as well as in controlling plaque accumulation and clinical attachment loss. |
Peri-implantitis | CHX 0.2% mouthwash, interdental brushes |
Powered and manual devices + LD of CHX 1% + Sx MD |
Peri-implantiti | |||||||||||||||
Costa et al. [31] | 2012 | Prospective study | Control | No | No | 41 | 183 | 60 | Mucositis |
16.7% sites with PD ≥ 5 mm |
41.5% implants show BL |
Sites: 50.2 to 62.6% |
NA |
1.6 (0.6) to 1.9 (0.5) |
% sites > 3 mm CAL 14.9 (16.7) to 22.7 (23.2) |
NA | NA | The absence of preventive maintenance in individuals with pre-existing peri-implant mucositis was associated with a high incidence of peri-implantitis. |
Test | OHI |
At least 5 SC, coronal prophylaxis |
39 | 157 |
5.9% sites with PD ≥ 5 mm |
17.9% implants show BL |
Sites: 41.7 to 33.3% |
NA |
1.4 (0.6) to 1.4 (0.7) |
% sites > 3 mm CAL 15.9 (19) to 20.1 (23) |
NA | NA | ||||||
Deppe et al. [32] | 2013 | Prospective study | Moderate bone loss | OHI, plaque control with use of CHX solution (0.3%) |
Calculus removal + antimicrobial PDT |
16 | 10 | 6 | Peri-implantitis |
3.3 (0.8) to 2.9 (0.5) |
3.9 (0.8) to 3.6 (0.8) mm |
Sulcus bleeding index: 1.8 (1.3) to 1.1 (0.9) |
NA | NA |
3.8 (1.3) to 3.6 (0.7) |
0.5 (0.5) to 0.7 (0.4) |
NA | Non-surgical PDT could stop bone resorption in moderate peri-implant defects but not in severe defects. marginal tissue recession was not significantly different in both groups. |
Severe bone lost | 8 |
5.8 (0.8) to 6.5 (0.9) |
6.8 (0.8) to 8.7 (0.7) |
Sulcus bleeding index: 1.5 (1.2) to 1.3 (1.1) |
NA | NA |
6.7 (0.9) to 8.1 (0.9) |
0.9 (1.2) to 1.6 (1.2) |
NA | |||||||||
Schwarz et al. [33] | 2015 | Prospective case series | MD + local antiseptic (MD + CHX) | OHI |
Supragingival calculus removal and supramucosal/gingival professional implant/ tooth cleaning + MD + CHX |
17 | 24 | 6 | Mucositis |
3.4 (0.5) to 3.3 (0.5) |
NA |
46.3 (23.5) to 8.3 (10.4)% |
NA |
0.7 (0.6) to 0.4 (0.5) |
NA | NA | NA | Non-surgical treatment of either peri-implant mucositis using MD + CHX or peri-implantitis using laser therapy at zirconia implants was associated with significant short-term clinical improvements. A complete disease resolution, however, was not achieved in the majority of the patients. |
Er:YAG laser therapy | OHI |
Supragingival calculus removal and supramucosal/ gingival professional implant/ tooth cleaning + laser tx |
17 | 21 | Peri-implantitis |
5.5 (0.5) to 4.5 (0.7) |
NA |
45 (18.5) to 14.2 (11.6)% |
NA |
0.6 (0.3) to 0.1 (0.1) |
NA | NA | NA |
ABX = antibiotics treatment; BOP = bleeding on probing; CAL = clinical attachment level; CHX = chlorhexidine digluconate; LD = local delivery; MBL = marginal bone level; MD = mechanical debridement; MPI = modified plaque index; NA = not available; PD = probing depth; PDT = photodynamic therapy; PI = plaque index; RB = radiographic bone; SD = standard deviation; Sx = surgery; TB = tooth brush. |